These findings have elucidated a mechanism whereby HBP1 and its negative feedback regulatory loop influence the development of T2DM, thereby providing a new theoretical basis and potential therapeutic target for T2DM. The gene discussed is HBP1; the disease is type 2 diabetes mellitus.